Effects of clozapine-N-oxide and compound 21 on sleep in laboratory mice [PDF]
Designer receptors exclusively activated by designer drugs (DREADDs) are chemogenetic tools for remote control of targeted cell populations using chemical actuators that bind to modified receptors. Despite the popularity of DREADDs in neuroscience and sleep research, potential effects of the DREADD actuator clozapine-N-oxide (CNO) on sleep have never ...
Jose Prius Mengual +12 more
openaire +6 more sources
Acute In Vivo Administration of Compound 21 Stimulates Akt and ERK1/2 Phosphorylation in Mouse Heart and Adipose Tissue. [PDF]
Quiroga DT +6 more
europepmc +1 more source
Potential nephroprotective effects of angiotensin II type 2 receptor agonist Compound 21 in renal ischemia-reperfusion injury. [PDF]
Kadhim LF +4 more
europepmc +1 more source
Compound 21, a Direct AT2R Agonist, Induces IL-10 and Inhibits Inflammation in Mice Following Traumatic Brain Injury. [PDF]
Ismael S, Ishrat T.
europepmc +1 more source
Compound 21, a two-edged sword with both DREADD-selective and off-target outcomes in rats. [PDF]
Goutaudier R +3 more
europepmc +1 more source
21-Derivatives of Compound S, Cortisone, and Hydrocortisone. [PDF]
Poul Borrevang, Lars Odin
openaire +1 more source
Delayed Administration of Angiotensin II Type 2 Receptor (AT2R) Agonist Compound 21 Prevents the Development of Post-stroke Cognitive Impairment in Diabetes Through the Modulation of Microglia Polarization. [PDF]
Jackson L +9 more
europepmc +1 more source
Pharmacokinetic and pharmacodynamic actions of clozapine-N-oxide, clozapine, and compound 21 in DREADD-based chemogenetics in mice. [PDF]
Jendryka M +7 more
europepmc +1 more source
Effects of compound 21, a non‑peptide angiotensin II type 2 receptor agonist, on general anesthesia‑induced cerebral injury in neonatal rats. [PDF]
Yong J, Yan L, Wang J, Xiao H, Zeng Q.
europepmc +1 more source
Renoprotective effects of compound 21 and empagliflozin in L-Name-induced hypertensive rats. [PDF]
Ozhan O +6 more
europepmc +1 more source

